Characteristics and outcome of respiratory syncytial virus infection in patients with leukemia

Abstract

RSV infection is associated with significant morbidity and mortality in leukemia patients; treatment with aerosolized ribavirin at the stage of URI may prevent pneumonia in some subsets of patients.